| Literature DB >> 33627617 |
Feng-Hao Liu1,2, Xiao-Zhong Jiang1,2, Bin Huang1, Yu Yu1.
Abstract
BACKGROUND This retrospective study aimed to identify the predictive factors for the progression of grade A, or early biochemical leak, to grade B postoperative pancreatic fistula (POPF) following pancreaticoduodenectomy using preoperative computed tomography (CT) imaging of the pancreas. MATERIAL AND METHODS A total of 156 patients were analyzed retrospectively. Biochemical leakage occurred in 60 patients, who were divided into POPF progression and non-POPF progression groups. Perioperative parameters were collected. Univariate analysis and multivariate logistic regression analysis were done. For the parameters with statistical significance, the area under the curve (AUC) was calculated if possible and the predictive value was assessed. RESULTS Univariate analysis showed that main pancreatic duct diameter, postoperative complications (except POPF), prothrombin time (PT) and serum albumin on postoperative day 3, and pancreatic CT value were risk factors of POPF (P<0.05). Multivariate analysis showed that serum albumin and PT on postoperative day 3 and pancreatic CT value were independent risk factors of POPF (P<0.05). Lower postoperative albumin, lower pancreatic CT value, and longer PT were associated with a higher risk of POPF (P<0.05). The AUC of CT value was 0.808. CT value thresholds of 42.5 Hounsfield units (HU) and 41.5 HU were tied for the highest predictive performance, with Youden indices of 0.486 for both, and sensitivity of 79% and 71%, and specificity of 69% and 78%, respectively. CONCLUSIONS Preoperative laboratory investigations and CT imaging of the pancreas may identify factors associated with early biochemical leakage progressing to grade B POPF following pancreaticoduodenectomy.Entities:
Mesh:
Year: 2021 PMID: 33627617 PMCID: PMC7923398 DOI: 10.12659/MSM.928489
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Univariate analysis of risk factors for progression from biochemical leak to grade B pancreatic fistula.
| Variable | Postoperative pancreatic fistula (POPF) progression | |||
|---|---|---|---|---|
| Yes | No | χ2 | ||
| Sex | ||||
| Male | 15 (62.5%) | 16 (44.4%) | 1.880 | 0.170 |
| Female | 9 (37.5%) | 20 (55.6%) | ||
| Age (yr) | 62.5±5.0 | 62.3±5.8 | 0.345 | 0.856 |
| BMI (kg/m2) | 24.60 (2.65) | 24.60 (3.00) | 0.955 | 0.683 |
| PT (s) | 12.60 (1.4) | 12.60 (1.2) | 0.598 | 0.833 |
| Serum albumin (g/L) | 35.40 (2.6) | 35.90 (2.4) | 0.996 | 0.752 |
| Preoperative total bilirubin | ||||
| ≥171 | 11 (45.8%) | 13 (36.1%) | 0.567 | 0.451 |
| <171 | 13 (54.2%) | 23 (63.9%) | ||
| Preoperative ALT (U/L) | 76.5±14.0 | 72.7±13.3 | 0.582 | 0.295 |
| Preoperative CT value | 40.1±2.7 | 43.9±3.4 | 0.426 | 0.0001 |
| MPD (mm) | ||||
| ≥3 | 8 (33.3%) | 24 (66.7%) | 6.429 | 0.011 |
| <3 | 16 (66.7%) | 12 (33.3%) | ||
| Operative time (min) | 366.3±20.9 | 358.0±23.9 | 0.370 | 0.177 |
| Blood loss (ml) | ||||
| ≥600 | 12 (50.0%) | 22 (61.1%) | 0.724 | 0.395 |
| <600 | 12 (50.0%) | 14 (38.9%) | ||
| Postoperative PT (s) | 16.4±1.3 | 14.8±1.2 | 0.879 | 0.0001 |
| Postoperative serum albumin (g/L) | 29.6±2.4 | 33.2±2.5 | 0.723 | 0.0001 |
| Postoperative total bilirubin (μmol/L) | ||||
| ≥171 | 9 (37.5%) | 10 (27.8%) | 0.629 | 0.428 |
| <171 | 15 (62.5%) | 26 (72.2%) | ||
| Postoperative ALT (U/L) | 54.4±9.9 | 52.2±5.9 | 0.166 | 0.302 |
| Postoperative complication | ||||
| Yes | 5 (20.8%) | 1 (3.0%) | 5.216 | 0.022 |
| No | 19 (79.2%) | 35 (97.0%) | ||
| Pathological type of tumour | ||||
| Benign tumour | 0 (0.0%) | 1 (2.8%) | 0.753 | 0.686 |
| Low grade malignant tumour | 1 (4.2%) | 1 (2.8%) | ||
| High grade malignant tumour | 23 (95.8%) | 34 (94.4%) | ||
yr – years old; postoperative – on postoperative 3 days; BMI – body mass index; PT – prothrombin time; ALT – alanine aminotransferase; MPD – main pancreatic duct. HU – Hounsfield Unit.
Values are mean±standard deviation;
median (interquartile range).
Multivariate logistic regression analysis of factors for progression from biochemical leak to grade B pancreatic fistula.
| Value | B | SE | Wals | OR | 95% CI | |
|---|---|---|---|---|---|---|
| Postoperative serum albumin (g/L) | −0.499 | 0.218 | 5.257 | 0.022 | 0.607 | 0.396~0.930 |
| MPD (mm) | 0.049 | 0.927 | 0.003 | 0.958 | 1.051 | 0.171~6.467 |
| Postoperative complication | 2.500 | 1.716 | 2.123 | 0.145 | 12.188 | 0.422~352.063 |
| Postoperative PT (s) | 1.084 | 0.504 | 4.617 | 0.032 | 2.955 | 1.100~7.941 |
| Preoperative CT value (HU) | −0.493 | 0.197 | 6.248 | 0.012 | 0.611 | 0.415~0.899 |
Postoperative – on postoperative 3 days; PT – prothrombin time; MPD – main pancreatic duct; CT – computed tomography; HU – Hounsfield Unit.
Figure 1Receiver operating characteristic (ROC) curve was drawn based on computed tomography (CT) value of pancreatic body.
Preoperative computed tomography (CT) value of the pancreatic body in the sensitivity and specificity for identifying progression from biochemical leak to grade B pancreatic fistula.
| CT value as the cut-off point | The sensitivity | The specificity | Youden index |
|---|---|---|---|
| 35.0 | 0.00 | 1.00 | 0.000 |
| 36.5 | 0.08 | 1.00 | 0.083 |
| 37.3 | 0.17 | 0.97 | 0.139 |
| 37.8 | 0.17 | 0.94 | 0.111 |
| 38.5 | 0.38 | 0.92 | 0.292 |
| 39.5 | 0.42 | 0.89 | 0.306 |
| 40.5 | 0.50 | 0.86 | 0.361 |
| 41.5 | 0.71 | 0.78 | 0.486 |
| 42.5 | 0.79 | 0.69 | 0.486 |
| 43.5 | 0.92 | 0.53 | 0.445 |
| 44.5 | 0.96 | 0.42 | 0.375 |
| 45.5 | 0.96 | 0.31 | 0.264 |
| 46.5 | 1.00 | 0.17 | 0.167 |
| 47.5 | 1.00 | 0.11 | 0.111 |
| 49.0 | 1.00 | 0.08 | 0.083 |
| 50.5 | 1.00 | 0.06 | 0.056 |
| 52.0 | 1.00 | 0.00 | 0.000 |
CT – computed tomography.